After working with both global pharma leaders and early-stage AI firms, I've seen a pattern: Par...

After working with both global pharma leaders and early-stage AI firms, I've seen a pattern: Partnerships, done right, are the only scalable route to real-world adoption of AI.

During WHX Tech, journalist Rachel McArthur interviewed me for HIMSS TV on this very topic.

We discussed the strategic value of collaboration (rather than going it alone) when bringing AI and TechBio solutions into clinical and operational environments.

I'd love to hear from peers across the ecosystem: what partnership strategies have worked for you (or not worked)?